Delisting Determination,The Nasdaq Stock Market, LLC,
October 6, 2011, Jiangbo Pharmaceuticals, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Jiangbo Pharmaceuticals, Inc.
(the Company), effective at the opening of the
trading session on October 17, 2011. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5101, 5605(c)(3), IM-5605,
and 5605(c)(2)(A). The Company was notified of the
Staffs determination on July 26, 2011. The Company
did not appeal the Staff determination to the Hearings
Panel. The Companys shares were suspended and the Staff
determination to delist the Company
became final on August 4, 2011.